EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting biofilm-driven antibiotic resistance: emerging mechanisms and next-generation therapeutic interventions

Abdulkarim Mbaraka, Ritu Raj Meena, Ekta Menghani, Nidhi Verma

Frontiers in Microbiology · 23.04.2026 · 17

DOI: 10.3389/fmicb.2026.1823476 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Microbiology, online erschienen am 23.04.2026. Verfasst von Abdulkarim Mbaraka und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Muhimbili University of Health and Allied Sciences (MUHAS), Dar es Salaam, Tanzania. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Biofilm mediated antimicrobial resistance (AMR) has become a critical global health and economic challenge, affecting both community and healthcare settings. Microbial Biofilms significantly enhance the antibiotic tolerance and cause the persistent and device-associated infections via limited drug penetration, degradation of antibiotics, and assist horizontal gene transfer. Biofilm-mediated antimicrobial resistance remains a major obstacle to treating infectious diseases today. Biofilms can boost antibiotic tolerance by up to 1,000 times and lead to chronic, persistent, and device-associated infections. The lack of FDA-approved anti-biofilm drugs highlights the urgent need for new therapeutic strategies and mechanistic insights. Redefining the treatment landscape and improving outcomes for resistant infections could be achieved through a multi-platform therapeutic approach. This review summarizes recent developments in our knowledge of how biofilms contribute to antibiotic resistance and highlights new therapeutic strategies, such as nanotechnology, antimicrobial peptides, bacteriophage-derived enzymes, quorum-sensing inhibitors, CRISPR-based tools, microbiome engineering, and AI-driven drug discovery.

Schlagwörter

Stichwörter der Autor:innen

ESKAPE pathogensantimicrobial resistancebiofilm-associated antibiotic resistancecombination therapyextracellular matrix

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biology, Muhimbili University of Health and Allied Sciences (MUHAS), Dar es Salaam, Tanzania.
  • Department of Biotechnology, JECRC University, Jaipur, Rajasthan, India.
  • Mahatma Gandhi Institute of Health Informatics (MGIHI), Mahatma Gandhi University of Medical Sciences and Technology, Jaipur, Rajasthan, India.

Zitieren

APA

Mbaraka, A., Meena, R. R., Menghani, E., & Verma, N. (2026). Targeting biofilm-driven antibiotic resistance: emerging mechanisms and next-generation therapeutic interventions. Frontiers in Microbiology, 17. https://doi.org/10.3389/fmicb.2026.1823476

Vancouver

Mbaraka A, Meena RR, Menghani E, Verma N. Targeting biofilm-driven antibiotic resistance: emerging mechanisms and next-generation therapeutic interventions. Frontiers in Microbiology. 2026;17. doi:10.3389/fmicb.2026.1823476

BibTeX
@article{Mbaraka2026,
  author = {Mbaraka, Abdulkarim and Meena, Ritu Raj and Menghani, Ekta and Verma, Nidhi},
  title = {Targeting biofilm-driven antibiotic resistance: emerging mechanisms and next-generation therapeutic interventions},
  journal = {Frontiers in Microbiology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fmicb.2026.1823476}
}
Kostenlos starten →